States’ Cosmetic Ingredient Legislation Also Touching Drugs Gets CHPA's Highlight Treatment

Bills Affecting Consumer Health Industry Also Found Concealed Around State Legislatures

“Lawmakers are not distinguishing between a cosmetic drug and a cosmetic that has no drug application at all,” says Carlos Gutierrez, CHPA’s state legislature lobby chief. Issues important to consumer health products industry can be found in unlikely places, he also tells HBW Insight.

• Source: Shutterstock

The OTC drug industry has another state legislation target to regularly track while also continuing to search in unlikely places for proposals with potential impact on manufacturing and marketing its products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

No Longer Voluntary, MoCRA Drives Drastic Increase In Registered Companies, Products

 
• By 

Preliminary registration data released by FDA offers a first glimpse of the Modernization of Cosmetics Regulation Act’s impact on information the agency has at hand.

WA Regulators Open Rulemaking On Cosmetic Lead Limits; Provide Safe Harbor Under TFCA

 

The Washington State Department of Ecology publishes ‘Interim Policy on Lead in Cosmetics’ which provides safe harbor options for cosmetic products struggling with the 1ppm limit under the state’s Toxic Free Cosmetics Act, while the department gathers information under a newly opened rulemaking to ‘identify a feasible approach to regulating lead in cosmetic products.’

WA State Regulators Haven’t Softened Stance On Preservatives, Provided Clarity On Penalties As TFCA Effective Date Nears

 

The Washington Department of Ecology hasn’t backed down on its targeting of formaldehyde-releasing preservatives under the state’s Toxic-Free Cosmetics Act, as industry still awaits a draft final rule. In a recent webinar, attorney Angela Deisch of Amin Wasserman Gurnani, LLP said the department has also not provided clarity on penalties under the law, which goes into effect 1 January.

Industry Support Key To US FDA’s Prospects Under Trump – Califf

 
• By 

The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."

More from Policy & Regulation

EU Wastewater Treatment Rule Draws ‘Unprecedented’ Cosmetics Industry Legal Challenge

 
• By 

The cosmetics industry in Europe, along with pharmaceuticals, has been directed to financially cover updates to European Union wastewater plants as part of an extended producer liability approach.

US Tariffs: Fragrance Industry Pushes For Exclusion Of Non-US Cultivated Materials, On Top Of Current Exemptions

 

Fragrance Creators Association will push the Trump Administration to exclude from tariffs fragrance materials that cannot be produced or cultivated domestically, while both FCA and the Personal Care Products Council will continue to promote the economic benefits of their respective industries.

Oregon EPR Reporting Deadline Passes, But Non-Compliant Firms Have One More Shot

 

Single-use packaging producers subject to Oregon state’s Extended Producer Responsibility law that didn’t meet the 31 March deadline to report their packaging materials are given a grace period to report until 30 April, says Circular Action Alliance, the organization carrying out the EPR program.